Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.
暂无分享,去创建一个
M. Humbert | X. Jaïs | G. Simonneau | P. Dorfmüller | C. Tcherakian | S. Feuillet | J. Le Pavec | A. Tazi | G. Lorillon